Hypertensive crisis resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Line 11: | Line 11: | ||
===Common Causes=== | ===Common Causes=== | ||
==Management== | ==Management== | ||
{{familytree/start}} | |||
{{familytree | | | | | A01 | | | | | | |A01=<div style="float: left; text-align: left; height: 15em; width: 20em; padding:1em;">'''Characterize the symptoms:''' <br> ❑ CNS - severe headache, dizziness, confusion, weakness/numbness, altered/LOC, difficulty speaking<br> ❑ Eyes - pain, blurred/loss of vision<br> ❑ Cardiopulmonary - chest pain, dyspnea<br>❑ Renal - hematuria, proteinuria, reduced urinary output<br>❑ Others - nausea/vomiting, severe anxiety, nosebleeds</div>}} | |||
{{familytree | | | | | |!| | |}} | |||
{{familytree | | | | | B01 | | |B01=<div style="float: left; text-align: left; height: 25em; width: 20em; padding:1em;">'''Evaluate the patient:''' <br> ❑ History<br>PMH especially HTN<br>Medications - dosages, compliance<br>Recreational drug use - methamphetamine, cocaine, phencyclidine<br> ❑ Physical<br>Blood pessure - both arms<br>Fundoscopy - papilledema, exudates, hemorrhages<br>Neuro exam - mental status, focal neurological deficits<br>Cardiopulmonary - signs of pulmonary edema<br>Abdomen - pulsatile masses, tenderness, bruits<br>Limbs - peripheral pulses</div>}} | |||
{{familytree | | | | | |!| | | | | |}} | |||
{{familytree | | | | | C01 |-| C02 | | |C01=<div style="float: left; text-align: left; height: 20em; width: 20em; padding:1em;">'''Order Labs:'''<br> ❑ CBC<br>❑ BMP + Mg + PO4<br> ❑ Serum uric acid<br> ❑ FLP<br> ❑ FBS <br> ❑ Urinalysis/culture<br> ❑ Urine electrolytes, creatinine, protein<br> ❑ Chest X-ray<br> ❑ EKG, ECHO<br> ❑ Renal USS + doppler</div>|C02=<div style="float: left; text-align: left; height: 22em; width: 20em; padding:1em;">'''Further work-up:'''<br> ❑ TSH, free T3, free T4<br> ❑ Serum cortisol<br> ❑ Serum aldosterone<br> ❑ Serum renin levels<br> ❑ HbA1C<br> ❑ 24-hr urinary catecholamine & metanephrine levels<br> ❑ Serum parathyroid hormone levels<br> ❑ Urine and serum toxicology screen<br> ❑ Urine pregnancy test<br> ❑ CT/MRI<br> ❑ DMSA/DTPA scans (renal scars)<br> ❑ ANA/ESR/CRP/anti-dsDNA/anti-smith/rheumatoid factor/p-ANCA/c-ANCA</div>}} | |||
{{familytree | | | | | |!| | | | |}} | |||
{{familytree | | | | | D01 | | | |D01='''Evidence of end organ damage''' (any of the symptoms above)}} | |||
{{familytree | |,|-|-|-|^|-|-|-|.| | |}} | |||
{{familytree | E01 | | | | | | E02 | |E01='''YES'''|E02='''NO'''}} | |||
{{familytree | |!| | | | | | | |!| | | |}} | |||
{{familytree | F01 | | | | | | F02 | | |F01=Hypertensive emergency<br>('''NB - Treat the patient and not the BP''')|F02=Hypertensive urgency}} | |||
{{familytree | |!| | | | | | | |!| | | |}} | |||
{{familytree | G01 |-|.| | | | G02 | | |G01=<div style="float: left; text-align: left; height: 26em; width: 20em; padding:1em;"><u>'''Admit ICU'''</u><br>Close BP monitoring<br>↓<br>Intra-arterial BP monitoring in severely-ill patients<br>↓<br>Assess volume status - IV N/S if volume depleted to prevent precipitous fall in BP following administration of antihypertensives<br>↓<br>Commence IV antihypertensives based on patient's symptom<br>↓<br>Change IV meds to oral when BP is stable<br>'''NB - Not more than 25% reduction in BP within the 1st hour; when BP is stable, reduce to 160/100-110 mmHg within the next 2-6 hours'''</div>|G02=<div style="float: left; text-align: left; height: 26em; width: 20em; padding:1em;"><u>'''Outpatient/Admit for obeservation'''</u><br>Oral antihypertensives<br>Clinical surveillance within the first few hours of commencing medications<br>'''NB - Gradual BP reduction over 24 - 48 hours'''</div>}} | |||
{{familytree | |!| | |!| | |,|-|^|-|.| | |}} | |||
{{familytree | H01 | |`|-| H02 | | H03 | |H01=<u>'''Special considerations'''</u><br>Malignant hypertension/Hypertensive encephalopathy<br>Cerebrovascular accident<br>Acute pulmonary edema<br>Acute aortic dissection<br>Angina pectoris/Acute MI<br>Sympathetic crisis<br>Preeclampsia/Eclampsia<br>Withdrawal of antihypertensive medication<br>Acute post-op hypertension|H02=Worsening blood pressure|H03=<u>'''Good control'''</u><br>Review old/start new medication<br>'''Modify risk factors'''<br>Close follow-up}} | |||
{{familytree/end}} | |||
==Dos== | ==Dos== | ||
==Don'ts== | ==Don'ts== |
Revision as of 17:11, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
Definitions
- Hypertensive urgencies - These are severe elevations in blood pressure with no or minimal evidence of target organ damage.[1] An example is a blood pressure of greater than 160/100 mmHg (stage 2 hypertension) associated with severe headache, shortness of breath, nosebleeds, or severe anxiety.
- Hypertensive emergencies - These are severe elevations in blood pressure, usually greater than 180/120 mmHg, complicated by evidence of impending or progressive target organ dysfunction. They warrant urgent blood pressure reduction by parenteral agents to prevent or limit target organ damage.[1] This is a clinical diagnosis. Examples include: hypertensive encephalopathy, intracerebral hemorrhage, acute myocardial infarction, e.t.c.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Characterize the symptoms: ❑ CNS - severe headache, dizziness, confusion, weakness/numbness, altered/LOC, difficulty speaking ❑ Eyes - pain, blurred/loss of vision ❑ Cardiopulmonary - chest pain, dyspnea ❑ Renal - hematuria, proteinuria, reduced urinary output ❑ Others - nausea/vomiting, severe anxiety, nosebleeds | |||||||||||||||||||||||||||||
Evaluate the patient: ❑ History PMH especially HTN Medications - dosages, compliance Recreational drug use - methamphetamine, cocaine, phencyclidine ❑ Physical Blood pessure - both arms Fundoscopy - papilledema, exudates, hemorrhages Neuro exam - mental status, focal neurological deficits Cardiopulmonary - signs of pulmonary edema Abdomen - pulsatile masses, tenderness, bruits Limbs - peripheral pulses | |||||||||||||||||||||||||||||
Order Labs: ❑ CBC ❑ BMP + Mg + PO4 ❑ Serum uric acid ❑ FLP ❑ FBS ❑ Urinalysis/culture ❑ Urine electrolytes, creatinine, protein ❑ Chest X-ray ❑ EKG, ECHO ❑ Renal USS + doppler | Further work-up: ❑ TSH, free T3, free T4 ❑ Serum cortisol ❑ Serum aldosterone ❑ Serum renin levels ❑ HbA1C ❑ 24-hr urinary catecholamine & metanephrine levels ❑ Serum parathyroid hormone levels ❑ Urine and serum toxicology screen ❑ Urine pregnancy test ❑ CT/MRI ❑ DMSA/DTPA scans (renal scars) ❑ ANA/ESR/CRP/anti-dsDNA/anti-smith/rheumatoid factor/p-ANCA/c-ANCA | ||||||||||||||||||||||||||||
Evidence of end organ damage (any of the symptoms above) | |||||||||||||||||||||||||||||
YES | NO | ||||||||||||||||||||||||||||
Hypertensive emergency (NB - Treat the patient and not the BP) | Hypertensive urgency | ||||||||||||||||||||||||||||
Admit ICU Close BP monitoring ↓ Intra-arterial BP monitoring in severely-ill patients ↓ Assess volume status - IV N/S if volume depleted to prevent precipitous fall in BP following administration of antihypertensives ↓ Commence IV antihypertensives based on patient's symptom ↓ Change IV meds to oral when BP is stable NB - Not more than 25% reduction in BP within the 1st hour; when BP is stable, reduce to 160/100-110 mmHg within the next 2-6 hours | Outpatient/Admit for obeservation Oral antihypertensives Clinical surveillance within the first few hours of commencing medications NB - Gradual BP reduction over 24 - 48 hours | ||||||||||||||||||||||||||||
Special considerations Malignant hypertension/Hypertensive encephalopathy Cerebrovascular accident Acute pulmonary edema Acute aortic dissection Angina pectoris/Acute MI Sympathetic crisis Preeclampsia/Eclampsia Withdrawal of antihypertensive medication Acute post-op hypertension | Worsening blood pressure | Good control Review old/start new medication Modify risk factors Close follow-up | |||||||||||||||||||||||||||
Dos
Don'ts
References
- ↑ 1.0 1.1 Chobanian, AV.; Bakris, GL.; Black, HR.; Cushman, WC.; Green, LA.; Izzo, JL.; Jones, DW.; Materson, BJ.; Oparil, S. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199. Unknown parameter
|month=
ignored (help)